Reg genes are CCK2 receptor targets in ElasCCK2 mice pancreas.
We previously demonstrated that expression of the gastrin receptor, CCK2R, in pancreatic acini of transgenic ElasCCK2 mice induced alteration of acinar morphology and differentiation, increased sensitivity to a carcinogen and development of preneoplastic lesions and tumours. Reg proteins are suggested to be involved in pancreatic cancer and in regeneration of endocrine pancreas. Reg I gene is a known target of gastrin. We examined whether an expression of CCK2R in the pancreatic acini of ElasCCK2 mice is linked to induction of Reg proteins expression. We analyzed Reg expression by Western-blot and immunohistochemistry in pancreas from ElasCCK2 and control mice. Islet neogenesis, glucose homeostasis, insulin secretion and content were also evaluated. Reg I is exclusively produced in acini in ElasCCK2 and control mice. In tumoral pancreas, Reg I and Reg III proteins are expressed in duct-like cells in preneoplastic lesions or in the periphery of tumours and in adjacent acini. The expression of Reg III proteins is increased in ElasCCK2 pancreas before the development of preneoplastic lesions in a subpopulation of islet cells and in small islet-like cell clusters dispersed within the acinar tissue. Several criteria of an enhanced neogenesis are fulfilled in ElasCCK2 pancreas. Moreover, ElasCCK2 mice have an improved response to glucose load, an increased insulin secretion and a doubling of insulin content compared to control mice. We show that Reg proteins are targets of CCK2R activation and are induced during early steps of carcinogenesis in ElasCCK2 mice pancreas. Alterations of exocrine tissue homeostasis in ElasCCK2 pancreas concomitantly activate regenerative responses of the endocrine pancreas possibly linked to paracrine actions of Reg III proteins.
Gigoux
V
V
Inserm, Institut National de la Santé et de la Recherche Médicale, Unit 858/I2MR, Institut Fédératif de Recherche 31, Toulouse, France.
Clerc
P
P
Sanchez
D
D
Coll
M G
MG
Corominola
H
H
Leung-Theung-Long
S
S
Pénicaud
L
L
Gomis
R
R
Seva
C
C
Fourmy
D
D
Dufresne
M
M
D000818:Animals; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D005786:Gene Expression Regulation; D005951:Glucose Tolerance Test; D007150:Immunohistochemistry; D007328:Insulin / Q000097:blood / Q000378:metabolism; D000078790:Insulin Secretion; D037181:Lectins, C-Type; D051379:Mice; D008822:Mice, Transgenic; D009929:Organ Size; D010179:Pancreas / Q000378:metabolism*; D000073718:Pancreatitis-Associated Proteins; D040081:Protein Array Analysis; D011506:Proteins / Q000235:genetics* / Q000378:metabolism; D043887:Receptor, Cholecystokinin B / Q000235:genetics / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D007328:Insulin; D037181:Lectins, C-Type; D000073718:Pancreatitis-Associated Proteins; D011506:Proteins; D043887:Receptor, Cholecystokinin B; C490253:Reg3b protein, mouse